Journal of Cardio-Oncology Case Reports: Case Reports in Cardio-Oncology Journal Publishes Case Reports in Pediatric Cardio-Oncology, Case Reports in Adult Cardio-Oncology, Clinical Images of Cardiology, Clinical Trials of Cardio-Oncology, Geriatric Oncology Case Reports, Clinical Imaging of Cardio-Oncology, Nursing Case Reports of Cardio-Oncology, Case Reports of Radiation Oncology, Case Reports in Translational Cardiology, Case Reports of Cardiotoxicity of anticancer drugs, Case Reports in Cardiotoxicity, Case Reports in Cardiovascular Injury, Case Reports in Pediatric onco-hematologists. Cardio-Oncology Case Reports will consider any original case report that expands the field of Cardiovascular knowledge, and original research relating to Cardio oncology case reports.
Journal of Cardio-Oncology Case Reports covers all aspects from Cardiovascular and Cancer sciences including Pediatric Cardio-Oncology, Adult Cardio-Oncology, Clinical Trials of Cardio-Oncology, Geriatric Cardio-Oncology, Imaging of Cardio-Oncology, Nursing in Cardio-Oncology, Radiation Cardio-Oncology, Cardiotoxicity of Anticancer Drugs, Patients at Risk of Cardiotoxicity, Cancer Patients to Cardiovascular Injury.
Journal of Cardio-Oncology Case Reports is an Editorial Tracking Based System for quality in review process for accepting original research and review articles from across the world. Review processing is performed by the editorial board members of Journal of Cardio-Oncology Case Reports or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole Submission, Review, Peer review, Revise, Publish process.
Manuscript Submission
Authors may submit their manuscripts through the journal's online submission portal:
https://www.cardiologycasereportsjournal.org/submit.html
(or) Send an e-mail attachment to the Editorial Office E-mail Id:
editor.clinical@cardiologycasereportsjournal.org
Pediatric Cardio-Oncology Journal
Case Reports in Pediatric Cardio-Oncology Journal is increasing numbers of patients at risk for cancer treatment-related cardiotoxicity (CTC) is an unintended consequence of successful therapy. In these patients, cardiovascular disease (CVD) has emerged as a leading cause of both morbidity and mortality and survivors are five to six times more likely than sibling controls to develop CVD of various etiologies. Anthracycline therapy has been the cornerstone of many chemotherapy regimens for pediatric patients since its introduction in the 1960s, and recent improved survival has been in large part due to advancements in chemotherapy, refinement of supportive care treatments.
Journal Of Adult Cardio-Oncology Case Reports
Case Reports in Adult Cardio-Oncology Journal is a growing field that seeks to merge cardiology and oncology fields to provide comprehensive care for patients before, during, and after cancer therapies. This is a complex interplay of inherent cardiovascular risk factors, potential cancer therapy-related toxicity, lifestyle effects, demographics, and social factors as well as genetics that interact to result in the development of cardiovascular diseases. Cancer treatments such as chemotherapy and radiation can control cancer, certain therapies may produce serious side effects on the heart. Cancer survivors may develop later complications such as arrhythmias, coronary artery disease, valvular heart disease and heart failure.
Clinical Trials of Cardio-Oncology Journal
Journal of Clinical Trials of Cardio-Oncology Case Reports is Cardio-oncology is an emerging field. Most of the data available have been issued from either retrospective analysis, industry data or pharmacovigilance data. Clinical Trials is a single tertiary centre prospective registry including all patients who have been referred for cardio-oncology assessemnt. The objectives are to provide a comprehensive of cardio-oncology, enable to detect early signals of cardiotoxicity and enhance ancillary projects aiming at specific populations and/or drugs.
Journal of Geriatric Cardio-Oncology Case Reports
Case Reports in Geriatric Cardio-Oncology Journal is the Crossroads of Geriatric Cardiology and Cardio-Oncology. Heart disease and cancer are the leading causes of death in older adults. Many first-line cancer treatments have the potential for cardiotoxicity. Cancer and cardiovascular disease (CVD) are two major causes of mortality in older adults. With improved survival and outcomes from cancer and CVD, the role of the geriatrician is evolving. Geriatricians provide key skills to facilitate patient-centered and value-based care in the growing older population of cancer patients.
Journal of Imaging of Cardio-Oncology
Case Reports in Imaging of Cardio-Oncology Journal is the world of cardio-oncology is an evolving field involving the assessment of cardiovascular disease in patients suffering from cancer. Cancer and cardiovascular diseases are the two leading causes of morbidity and mortality in the developed world. Cardiovascular imaging (CVI) plays a significant role in each of these scenarios and has broadened from predominantly quantifying left ventricular function (specifically ejection fraction) to the identification of earlier bio-signatures of CTRCD.
Nursing in Cardio-Oncology Journal
Case Reports of Nursing in Cardio-Oncology Journal is a unique subspecialty within oncology nursing that focuses on the assessment, identification, and management of cardiotoxicity induced or exacerbated by cancer treatment. Nurses are pivotal to the delivery of evidence-based assessment of and care for individuals who have preexisting cardiac conditions, as well as those for whom cardiac complications are related to the known and emerging toxicities of cancer treatment.
Case Reports in Radiation Cardio-Oncology Journal
Journal of Radiation Cardio-Oncology Case Reports Cardiac toxicity is a known side effect of radiation therapy delivered to the thoracic region. Therapeutic radiation plays a role in the treatment of many malignant and a few benign conditions. Radiation-induced cardiac toxicity, cardiac toxicity mitigation techniques, and the need for team-based monitoring and identification of undesired cardiac toxicity to improve long-term patient outcomes.
Radiation therapy demonstrates a clear survival benefit in the treatment of several malignancies. However, cancer survivors can develop a wide array of cardiotoxic complications related to radiation. Radiation heart disease is a side effect of radiation therapy for cancers in the chest and includes a wide range of heart conditions. Because it can occur many years after exposure, close monitoring is essential. Advances in cancer radiation technology are reducing radiation exposure to the heart and the risk of heart disease.
Cardiotoxicity of Anticancer Drugs Journal
Journal of Cardiotoxicity of Anticancer Drugs Case Reports is Chemotherapy and targeted therapies have significantly improved the prognosis of oncology patients. However, these antineoplastic treatments may also induce adverse cardiovascular effects. Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
Patients at Risk of Cardiotoxicity Journal
Journal of Patients at Risk of Cardiotoxicity Case Reports is anticancer therapy affects heart function and structure. Cardiotoxicity can also lead to accelerated development of chronic diseases, especially in the presence of risk factors. Cardiotoxicity refers to any heart damage arising from cancer treatment. It is not common overall but may be common in people who take certain chemotherapy or targeted therapy drugs. You may also develop heart problems after having radiation therapy to the chest. Cardiotoxicity sometimes develops years after cancer treatment.
Cancer Patients to Cardiovascular Injury Journal
Case Reports in Cancer Patients to Cardiovascular Injury Journal Cardiotoxicity is a term for any heart damage arising from cancer treatments. It's more common in people who have used specific chemotherapy or targeted therapy drugs. It may also develop in people who have had radiation therapy to the chest. Heart problems are an uncommon but serious side effect of some cancer treatments. The medical term cardiac toxicity refers to this type of side effect. Heart problems caused by cancer treatment can: Affect the dose or type of cancer treatment you receive, Affect your quality of life, In rare cases, cause death.
